| ²é¿´: 679 | »Ø¸´: 1 | |||
| ±¾Ìû²úÉú 1 ¸ö ·ÒëEPI £¬µã»÷ÕâÀï½øÐв鿴 | |||
zhangrong7882Òø³æ (³õÈëÎÄ̳)
|
[ÇóÖú]
ҽѧÀàÒ»¶ÎÖÐÎÄ·Òë³ÉÓ¢ÎÄ£¬Ð»Ð»£¬24hÄÚ
|
||
|
ÁÙ´²Ç°Ñо¿½á¹ûÇå³þµÄ±íÃ÷L-BLP25Äܹ»ÓÕµ¼Ï¸°ûµÄ¿¹Ö×ÁöÃâÒßÓ¦´ð¡£ÔÚʹÓÃL-BLP25ÃâÒß½ÓÖÖµÄСÊóÖУ¬¿É¹Û²ìµ½¿¹ÔÌØÒìÐÔµÄTϸ°ûÔöÖ³£¬ÒÔ¼°CD4+ϸ°ûIFN£µÄÉú³É¡£ÔÚ¾¹ýL-BLP25½ÓÖÖµÄСÊóÖУ¬»¹¹Û²ìµ½ÆäËüһЩϸ°ûÒò×Ó¡£ÔÚ±»L-BLP25ÃâÒß½ÓÖÖµÄСÊóÖгöÏÖ¶ÔMUC1¾ßÓÐÌØÒìϸ°û¶¾ÐÔµÄTϸ°ûÓ¦´ð¡£Ê¹ÓÃL-BLP25½ÓÖÖÄܹ»ÏÔÖøÒÖÖÆMC38/MUC1СÊóÖ×ÁöÄ£ÐÍÖÐÖ×ÁöµÄÉú³¤¡£ÔÚÈËÌåÖУ¬Õý³£Ï×ѪÕßѪҺÖеÄTϸ°û±©Â¶ÓÚ¾ÃâÒß½ÓÖÖµÄÊ÷ͻ״ϸ°ûºó£¬¿É¹Û²ìµ½BLP25ÌØÒìÐÔTϸ°ûµÄÔöÖ³¡£ [ Last edited by zhangrong7882 on 2011-6-29 at 20:15 ] |
» ²ÂÄãϲ»¶
298Çóµ÷¼Á
ÒѾÓÐ7È˻ظ´
263Çóµ÷¼Á
ÒѾÓÐ5È˻ظ´
276Çóµ÷¼Á¡£ÓаëÄêµç³ØºÍ°ëÄê¸ß·Ö×Óʵϰ¾Àú
ÒѾÓÐ6È˻ظ´
Çóµ÷¼Á²ÄÁÏѧ˶080500£¬×Ü·Ö289·Ö
ÒѾÓÐ21È˻ظ´
±±¿Æ281ѧ˶²ÄÁÏÇóµ÷¼Á
ÒѾÓÐ8È˻ظ´
2026»¯Ñ§µ÷¼Á
ÒѾÓÐ3È˻ظ´
08¹¤Ñ§µ÷¼Á
ÒѾÓÐ9È˻ظ´
291 Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
070300»¯Ñ§Çóµ÷¼Á
ÒѾÓÐ5È˻ظ´
085600²ÄÁÏÓ뻯¹¤
ÒѾÓÐ10È˻ظ´
8814402
ÖÁ×ðľ³æ (Ö°Òµ×÷¼Ò)
- ·ÒëEPI: 509
- Ó¦Öú: 18 (СѧÉú)
- ¹ó±ö: 0.381
- ½ð±Ò: 12916.1
- É¢½ð: 47
- ºì»¨: 16
- Ìû×Ó: 4183
- ÔÚÏß: 357.8Сʱ
- ³æºÅ: 1184404
- ×¢²á: 2011-01-06
- רҵ: Ò©ÎïѧÆäËû¿ÆÑ§ÎÊÌâ
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï ¡ï
sltmac(½ð±Ò+2): ллӦÖú~~ 2011-06-30 09:01:14
zhangrong7882(½ð±Ò+50, ·ÒëEPI+1): ·µÃºÜºÃ£¬Ð»Ð» 2011-06-30 20:27:54
sltmac(½ð±Ò+2): ллӦÖú~~ 2011-06-30 09:01:14
zhangrong7882(½ð±Ò+50, ·ÒëEPI+1): ·µÃºÜºÃ£¬Ð»Ð» 2011-06-30 20:27:54
| ÁÙ´²Ç°Ñо¿½á¹ûÇå³þµÄ±íÃ÷L-BLP25Äܹ»ÓÕµ¼Ï¸°ûµÄ¿¹Ö×ÁöÃâÒßÓ¦´ð¡£Results of preclinical studies indicated clearly that L-BLP25 can induce anticancer immune response of cells.ÔÚʹÓÃL-BLP25ÃâÒß½ÓÖÖµÄСÊóÖУ¬¿É¹Û²ìµ½¿¹ÔÌØÒìÐÔµÄTϸ°ûÔöÖ³£¬ÒÔ¼°CD4+ϸ°ûIFN£µÄÉú³É¡£ÔÚ¾¹ýL-BLP25½ÓÖÖµÄСÊóÖУ¬»¹¹Û²ìµ½ÆäËüһЩϸ°ûÒò×Ó¡£ÔÚ±»L-BLP25ÃâÒß½ÓÖÖµÄСÊóÖгöÏÖ¶ÔMUC1¾ßÓÐÌØÒìϸ°û¶¾ÐÔµÄTϸ°ûÓ¦´ð¡£Among the mice immunizated with L-BLP25, T-cell proliferation with antigenic specificity and CD4+ cell IFN- generation can be observed; other cell factors also can be observed and T-cell response with specific cytotoxicity to MUC1 appeared.ÔÚʹÓÃL-BLP25½ÓÖÖÄܹ»ÏÔÖøÒÖÖÆMC38/MUC1СÊóÖ×ÁöÄ£ÐÍÖÐÖ×ÁöµÄÉú³¤¡£Tumour growth in MC38/MUC1 mice tomour models can be restrained through L-BLP25 immunization. ÈËÌåÖУ¬Õý³£Ï×ѪÕßѪҺÖеÄTϸ°û±©Â¶ÓÚ¾ÃâÒß½ÓÖÖµÄÊ÷ͻ״ϸ°ûºó£¬¿É¹Û²ìµ½BLP25ÌØÒìÐÔTϸ°ûµÄÔöÖ³¡£In human body, T-cell proliferation with BLP25 specificity can be observed when T-cells in blood of normal blood donors were exposed to immunizated dendritic cells. |
2Â¥2011-06-30 08:57:51













»Ø¸´´ËÂ¥